Isomorphic Labs Unveils Drug Design Engine
andsoitis · hn · 2026-07-18
Isomorphic Labs has published an article introducing its **drug design engine**, emphasizing it as a new phase beyond AlphaFold. The core message is that the team is no longer limited to protein structure prediction. Instead, AI is being applied to **drug design and molecular optimization**, integrating structures, biology, and design processes to target a more complete R&D workflow. The article describes this engine as a new frontier, framing the transition from "seeing structures" to "designing molecules."
More from Companies & People
- Kunlun Spins Out Riemann Dynamics, Unveils World Action Model for Robotics — 0xAllen_ · 2026-07-21
- Qdrant co-hosts a Munich meetup on search, retrieval, and agentic RAG on July 23 — qdrant_engine · 2026-07-21
- Jamie Dimon says bureaucracy, not AI, is the real system crushing intelligence — r0ck3t23 · 2026-07-21
- Sophos joins Anthropic’s Project Glasswing to use Claude Mythos 5 for vulnerability hunting — TechNadu · 2026-07-21
- OpenAI and Anthropic’s internal models are said to be far stronger than today’s public systems — scaling01 · 2026-07-21
- A developer’s Codex usage is draining pooled enterprise credits at a small company — Distinct_Relation_62 · 2026-07-21